Amgen AMGN
NASDAQ AMGN
$433.73 -8.63 (-1.95%)
At close: Aug 20, 2026 · 4:00 PM EDT

Amgen (AMGN) EBIT (2009 - 2026)

Amgen (AMGN) posted quarterly EBIT of $2.7 billion for Q1 2026, up 126.32% year-over-year from $1.2 billion in Q1 2025, and down 1.99% quarter-over-quarter from $2.7 billion in Q4 2025.

Amgen (AMGN) EBIT (2009 - 2026) Analysis & Trends

Amgen's EBIT history runs 18 years deep, the most recent figure standing at $2.7 billion for Q1 2026.

  • In Q1 2026, EBIT rose 126.32% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $10.6 billion (up 41.95% YoY), while the FY2025 annual figure was $9.1 billion, up 25.1% from the prior year.
  • EBIT for Q1 2026 stood at $2.7 billion, down from $2.7 billion in the prior quarter.
  • The five-year high for EBIT was $2.7 billion in Q4 2025, with the low at $991.0 million in Q1 2024.
  • The 5-year median for EBIT is $2.2 billion (2022), against an average of $2.1 billion.
  • The sharpest annual moves came in 2022 and 2024: EBIT soared 162.8% in 2022, then slumped 48.41% in 2024.
  • Amgen's EBIT stood at $2.2 billion in 2022, then plunged by 43.0% to $1.3 billion in 2023, then surged by 81.83% to $2.3 billion in 2024, then increased by 17.7% to $2.7 billion in 2025, then fell by 1.99% to $2.7 billion in 2026.
  • Business Quant data shows AMGN's EBIT at $2.7 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.5 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 7.14 Bn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 6.43 Bn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 3.16 Bn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -10.39 Bn
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 4.27 Bn
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 645.35 Mn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 16.77 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.51 Bn
Mar 31, 2026 2.67 Bn
Dec 31, 2025 2.72 Bn
Sep 30, 2025 2.53 Bn
Jun 30, 2025 2.66 Bn
Mar 31, 2025 1.18 Bn
Dec 31, 2024 2.31 Bn
Sep 30, 2024 2.05 Bn
Jun 30, 2024 1.91 Bn
Mar 31, 2024 991.00 Mn
Dec 31, 2023 1.27 Bn
Sep 30, 2023 2.02 Bn
Jun 30, 2023 2.68 Bn
Mar 31, 2023 1.92 Bn
Dec 31, 2022 2.23 Bn
Sep 30, 2022 2.66 Bn
Jun 30, 2022 2.18 Bn
Mar 31, 2022 2.50 Bn
Dec 31, 2021 2.30 Bn
Sep 30, 2021 2.38 Bn